BOCA RATON, Fla.--(BUSINESS WIRE)--Jan. 25, 2016--
TherapeuticsMD, Inc. (NYSE MKT: TXMD) ("TherapeuticsMD" or the
"Company"), an innovative women's healthcare company and parent company
of vitaMedMD, LLC ("vitaMedMD"), announced today the launch of
vitaMedMD’s newest prescription prenatal multivitamin, vitaTrue, adding
to its successful prenatal line consisting of vitaPearl™, vitaMedMD One
Rx, vitaMedMD Plus Rx, and vitaMedMD RediChew™ Rx.
VitaTrue offers women with vegan or kosher preferences and who are
planning a pregnancy, pregnant, or nursing a complete prenatal
multivitamin without compromises. Jason Spitz, Vice President of
Marketing, stated, "vitaMedMD has once again listened and responded to
the needs of women and the healthcare community for comprehensive
nutritional support in the prenatal space, specifically creating a
prenatal vitamin that is both certified vegan and certified kosher. Like
all vitaMedMD prenatal vitamins, vitaTrue is gluten-free, lactose-free,
and sugar-free. Additionally, vitaTrue is fish-free and gelatin-free.”
VitaTrue contains 16 vitamins and minerals, including 40% more folic
acid than the leading prescription prenatal vitamins, and 300 mg of
vegan, plant-based DHA. VitaTrue is available by prescription through
retail and mail order pharmacies nationwide beginning today.
VitaTrue – Stay True to You!
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is an innovative healthcare company focused on
developing and commercializing products exclusively for women. With its
SYMBODA™ technology, TherapeuticsMD is developing advanced
hormone therapy pharmaceutical products to enable delivery of
bio-identical hormones through a variety of dosage forms and
administration routes. The company’s clinical development pipeline
includes two phase 3 products. The company manufactures and distributes
branded and generic prescription prenatal vitamins as well as
over-the-counter vitamins under the vitaMedMD® and BocaGreenMD®
brands. More information is available at the following websites: www.therapeuticsmd.com,
View source version on businesswire.com: http://www.businesswire.com/news/home/20160125005005/en/
Source: TherapeuticsMD, Inc.
Dan Cartwright, 561-961-1900
Director, Media & Engagement, WCG